Peripheral neuropathy in patients with inflammatory bowel disease

Brain

Volumn 128, Issue 4, 2005, Pages 867-879

  Gondim, F A A ^a,b   Brannagan III, Thomas H ^a   Sander, H W ^a   Chin, R L ^a   Latov, N ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

CIDP; Crohn's disease; Inflammatory bowel disease; Peripheral neuropathy; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; ETANERCEPT; FLUDARABINE; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; METRONIDAZOLE; PREDNISONE; STEROID; VINCRISTINE;

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; COLON RESECTION; CROHN DISEASE; DEMYELINATING DISEASE; DEMYELINATING NEUROPATHY; ENTERITIS; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; NERVE BIOPSY; PERIPHERAL NEUROPATHY; PHENOTYPE; PLASMAPHERESIS; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT OUTCOME; ULCERATIVE COLITIS; AGE; AGED; MIDDLE AGED; MUSCLE CELL; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGE FACTORS; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; DEMYELINATING DISEASES; FEMALE; HUMANS; IMMUNOTHERAPY; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MUSCLE FIBERS; PERIPHERAL NERVOUS SYSTEM DISEASES; RETROSPECTIVE STUDIES; SEX FACTORS; TREATMENT OUTCOME;

EID: 16844364822     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awh429     Document Type: Article

References (65)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991; 41: 617-18.
2. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989; 46: 878-84.
3. Blin O, Sangla I, Jouglard J, Cottin C, Pellissier JF, Serratrice G. Axonal neuropathy and salazosulphapyridine: slow acetylator phenotype. Rev Neurol (Paris) 1992; 148: 154-6.
4. Boyce EG, Cookson ET, Bond WS. Persistent metronidazole-induced peripheral neuropathy. DICP 1990; 24: 19-21.
5. Bradley WG, Karlsson IJ, Rassol CG. Metronidazole neuropathy. Br Med J 1977; 2(6087): 610-11.
6. Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 1982; 83: 383-7.
7. Briani C, Brannagan TH, Trojaborg W, Latov N. Chronic inflammatory demyelinating polyneuropathy. Neuromuscul Disord 1996; 6: 311-25.
8. Chad DA, Smith TW, DeGirolami U, Hammer K. Perineuritis and ulcerative colitis. Neurology 1986; 36: 1377-9.
9. Chaoui F, Hellal H, Balamane M, Boudhane M, Mikol J, Masmoudi A. Colonic Crohn's disease complicated with peripheral neuropathy. Gastroenterol Clin Biol 1990; 14: 869-72.
10. Chin RL, Sander HW, Brannagan TH, Green PH, Hays AP, Alaedini A et al. Celiac neuropathy. Neurology 2003; 60: 1581-5.
11. Coert JH, Dellon AL. Neuropathy related to Crohn's disease treated by peripheral nerve decompression. Scand J Plast Reconstr Surg Hand Surg 2003; 37: 243-4.
12. Cohen MG, Webb J. Brachial neuritis with colitic arthritis. Ann Intern Med 1987; 106: 780-1.
13. Couratier P, Truong CT, Khalil M, Preux PM, Tarabaud F, Vallat JM. Cranial nerve palsies in a multifocal demyelinating neuropathy with persistent nerve block associated with hemorrhagic ulcerative colitis. Rev Neurol (Paris) 2000; 156: 179.
14. Contamin F, Ollat H, Levy VG, Thierman-Duffaud D. Involvement of the peripheral and pyramidal nervous system in Crohn disease. Determining role of folic acid deficiency. Sem Hop 1983; 59: 1381-5.
15. Coxon A, Pallis CA. Metronidazole neuropathy. J Neurol Neurosurg Psychiatry 1976; 39: 403-5.
16. Crespi V, Bogliun G, Marzorati L, Zincone A, D'Angelo L, Liberani A et al. Inflammatory bowel disease and peripheral neuropathy. J Neurol 1994; 241 (Suppl 1): 63.
17. de la Fuente-Fernandez R, Rubio-Nazabal E, de la Iglesia-Martinez F. Guillain-Barre syndrome as an extraintestinal manifestation of Crohn's disease. Postgrad Med J 1995; 71: 437-8.
18. Dubois A, Raffanel C, Pignodel C, Janbon C, Marty-Double C, Balmes P. Acute cerebellar syndrome associated with sensory neuropathy in a patient treated with metronidazole. Presse Med 1983; 12: 1547-8.
19. Duffy LF, Daum F, Fisher SE, Selman J, Vishnubhakat SM, Aiges HW et al. Peripheral neuropathy in Crohn's disease patients treated with metronidazole. Gastroenterology 1985; 88: 681-4.
20. Elsehety A, Bertorini TE. Neurologic and neuropsychiatrie complications of Crohn's disease. South Med J 1997; 90: 606-10.
21. Friedman S, Blumberg RS. Inflammatory bowel disease. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of internal medicine. 15th ed. McGraw-Hill Professional; 2001, Online edition.
22. Gariballa SE, Gunasekera NP. Bilateral foot drop, weight loss and rectal bleeding as an acute presentation of Crohn's disease. Postgrad Med J 1994; 70: 762-3.
23. Gastaut JL. Painful legs and moving toes. A drug-induced case. Rev Neurol (Paris) 1986; 142: 641-2.
24. Gendelman S, Present D, Janowitz HD. Neurological complications of inflammatory bowel disease. Gastroenterology 1982; 82: 1065.
25. George WL, Kirby BD, Sutler VL, Wheeler LA, Mulligan ME, Finegold SM. Intravenous metronidazole for treatment of infections involving anaerobic bacteria. Antimicrob Agents Chemother 1982; 21: 441-9.
26. Gondim FAA, Brannagan TH, Sander H, Chin RL, Latov N. Peripheral neuropathy in patients with inflammatory bowel disease. Neurology 2004; 62 (Suppl 5): A263.
27. Greco F, Pavone P, Falsaperla R, Sorge G. Peripheral neuropathy as first sign of ulcerative colitis in a child. J Clin Gastroenterol 2004; 38: 115-17.
28. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine 1976; 55: 401-12.
29. Gupta BS, Baldwa S, Verma S, Gupta JB, Singhal A. Metronidazole induced neuropathy. Neurol India 2000; 48: 192-3.
30. Hishon S, Pilling J. Metronidazole neuropathy (letter). Br Med J 1977; 2: 832.
31. Holdstock DJ. Letter: Drug treatment in Crohn's disease. Lancet 1975; 2(7947): 1260.
32. Humbert P, Monnier G, Billerey C, Birgen C, Dupond JL. Polyneuropathy: an unusual extraintestinal manifestation of Crohn's disease. Acta Neurol Scand 1989; 80: 301-6.
33. Karlsson IJ, Hamlyn AN. Metronidazole neuropathy. Br Med J 1977; 3: 832.
34. Konagaya Y, Konagaya M, Takayanagi T. Chronic polyneuropathy and ulcerative colitis. Jpn J Med 1989; 28: 72-4.
35. Kusumi RK, Plouffe JF, Wyatt RH, Fass RJ. Central nervous system toxicity associated with metronidazole therapy. Ann Intern Med 1980; 93: 59-60.
36. Lagueny A, Vallat JM, Lamouliate H, Dubarry JJ. Sensory neuropathy and metronidazole. Apropos of a recent case with ultrastructural study. Sem Hop 1977; 53: 2207.
37. Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 2003; 9: 2300-7.
38. Larrodé P, Ramon Y Cajal S, Iniguez C, Sopena F, Gonzalez P, Morales F. Peripheral neuropathy associated with intestinal inflammatory disease. Neurologia 2001; 16: 133-7.
39. Lindgren S, Lilja B, Rosen I, Sundkvist G. Disturbed autonomic nerve function in patients with Crohn's disease. Scand J Gastroenterol 1991; 26: 361-6.
40. Lindgren S, Stewenius J, Sjolund K, Lilja B, Sundkvist G. Autonomic vagal nerve dysfunction in patients with ulcerative colitis. Scand J Gastroenterol 1993; 28: 638-42.
41. Losses A, Argov Z, Ackerman Z, Abramsky O. Peripheral neuropathy and folate deficiency as the first sign of Crohn's disease. J Clin Gastroenterol 1991; 13: 442-4.
42. Losses A, River Y, Eliakim A, Steiner I. Neurologic aspects of inflammatory bowel disease. Neurology 1995; 45: 416-21.
43. Magda P, Latov N, Brannagan TH 3rd, Weimer LH, Chin RL, Sander HW. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 2003; 60: 1755-9.
44. McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fibre density: normative reference range and diagnostic efficiency. Arch Neurol 1998; 55: 1513-20.
45. Moormann B, Herath H, Mann O, Ferbert A. Involvement of the peripheral nervous system in Crohn's disease. Nervenarzt 1999; 70: 1107-11.
46. Nemni R, Fazio R, Corbo M, Sessa M, Comi G, Canal N. Peripheral neuropathy associated with Crohn's disease. Neurology 1987; 37: 1414-17.
47. Okayama R, Yamada M, Tamaki M, Orimo S, Arai M. Mononeuropathy multiplex with ulcerative colitis. Intern Med 1993; 32: 651-4.
48. Olney RK, Lewis RA, Putnam TD, Campellone JV Jr; American Association of Electrodiagnostic Medicine. Consensus criteria for the diagnosis of multifocal motor neuropathy. Muscle Nerve 2003; 27: 117-21.
49. Ramsay ID. Endocrine ophthalmopathy. Br Med J 1968; 4: 706.
50. Rankin GB, Watts HD, Melnyk CS, Kelley ML Jr. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology. 1979; 77: 914-20.
51. Roca B, Moreno I, Meneu E. Ulcerative colitis and acquired demyelinating neuropathy (Guillain-Barre syndrome). Neth J Med 1999; 54: 129-30.
52. Said G, Goasguen J, Laverdant C. Neuropathy in long term treatment with metronidazole. Rev Neurol (Paris) 1978; 134: 515-21.
53. Saito M, Hozumi I, Kawakami A, Tsuji S. A case of post-rubella Guillain-Barre syndrome associated with ulcerative colitis. Rinsho Shinkeigaku 1994; 34: 1121-24 (abstract in English).
54. Schipper H, Beale FA, Bush RS, Fryer C. Metronidazole as a radiosensitizer (response). N Engl J Med 1976; 294: 901.
55. Stahlberg D, Barany F, Einarsson K, Ursing B, Elmqvist D, Persson A. Neurophysiologic studies of patients with Crohn's disease on long-term treatment with metronidazole. Scand J Gastroenterol 1991; 26: 219-24.
56. Steiner I, Wirguin I, Abramsky O. Appearance of Guillain-Barre syndrome in patients during corticosteroid treatment. J Neurol 1986; 233: 221-3.
57. Straub RH, Antoniou E, Zeuner M, Gross V, Scholmerich I, Andus T. Association of autonomic nervous hyperreflexia and systemic inflammation in patients with Crohn's disease and ulcerative colitis. J Neuroimmunol 1997; 80: 149-57.
58. Takeuchi H, Yamada A, Touge T, Miki H, Nishioka M, Hashimoto S. Metronidazole neuropathy: a case report. Jpn J Psychiatry Neurol 1988; 42: 291-5.
59. Tomer G, Ceballos C, Concepcion E, Benkov KJ. NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease. Am J Gastroenterol 2003; 98: 2479-84.
60. Ursing B, Kamme C. Metronidazole for Crohn's disease. Lancet 1975 Apr 5; 1(7910): 775-7.
61. Ursing B, Alm T, Barany F, Bergelin I, Ganrot-Norlin K, Hoevels J et al. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result. Gastroenterology 1982; 83: 550-62.
62. Vinals M, Anciones B, Cruz Martinez A, Barreiro P. Recurrent Miller-Fisher syndrome associated with brachial neuritis. Neurologia 1989; 4: 61-5.
63. You B, Grilliat JP. Metronidazole neuropathy. Nouv Presse Med 1981; 10: 708.
64. Zimmerman J, Steiner I, Gavish D, Argov Z. Guillain-Barré syndrome: a possible extraintestinal manifestation of ulcerative colitis. J Clin Gastroenterol 1985; 7: 301-3.
65. Zincone A, Bogliun G, Crespi V, Marzorati L, D'Angelo L, Beretta L et al. Autonomic neuropathy in ulcerative colitis. Scand J Gastroenterol 1995; 30: 399-400.